We are live on ! Find out more
SEM

Select Medical

Delisted

SEM was delisted on the 30th of June, 2026.

180 hedge funds and large institutions have $2.02B invested in Select Medical in 2017 Q3 according to their latest regulatory filings, with 33 funds opening new positions, 56 increasing their positions, 62 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

450% more first-time investments, than exits

New positions opened: 33 | Existing positions closed: 6

27% more call options, than puts

Call options by funds: $2.47M | Put options by funds: $1.94M

24% more capital invested

Capital invested by funds: $1.62B → $2.02B (+$394M)

16% more funds holding

Funds holding: 155180 (+25)

10% less repeat investments, than reductions

Existing positions increased: 56 | Existing positions reduced: 62

1.11% less ownership

Funds ownership: 147.93%146.82% (-1.1%)

50% less funds holding in top 10

Funds holding in top 10: 21 (-1)

Holders
180
Holders Change
+25
Holders Change %
+16.13%
% of All Funds
4.49%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
33
Increased
56
Reduced
62
Closed
6
Calls
$2.47M
Puts
$1.94M
Net Calls
+$523K
Net Calls Change
+$515K

SEM Hedge Fund Activity: Q3 2017 in Review

180 of the 4,012 institutional investors tracked by Wall St. Rank reported a position in Select Medical (SEM) for Q3 2017, worth a combined $2.02B — up 24% from $1.62B a quarter earlier.

Buyers outnumbered sellers: 33 funds opened new SEM positions and 6 closed out — a net gain of 27 holders — while 56 added to existing stakes and 62 trimmed.

The largest buyer was OrbiMed, adding an estimated $32.4M. The largest seller was Camber Capital Management, exiting entirely with an estimated $76.8M sold.

  • 180 institutional investors held Select Medical (SEM) as of Q3 2017, up from 155 in Q2 2017.
  • Funds reported $2.02B of Select Medical stock for Q3 2017, up 24% quarter-over-quarter.
  • 33 funds opened new Select Medical positions in Q3 2017 and 6 closed out, a net change of +27 holders.
  • The largest Select Medical buyer in Q3 2017 was OrbiMed, an estimated $32.4M added.
  • The largest Select Medical seller in Q3 2017 was Camber Capital Management, an estimated $76.8M sold.

Based on aggregated 13F filings for Q3 2017.